ARTICLE | Top Story
Ultragenyx raises $75 million in series B
December 21, 2012 2:06 AM UTC
Rare disease company Ultragenyx Pharmaceutical Inc. (Novato, Calif.) raised $75 million in a series B round led by new investor Adage Capital Partners. New investors T. Rowe Price; Jennison Associates; BlackRock BioCapital; Sanofi-Genzyme BioVentures; and Shire plc (LSE:SHP; NASDAQ:SHPG) also participated, along with existing investors TPG Biotech; Fidelity Biosciences; HealthCap; and Pappas Ventures. ...